• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式心脏复律除颤器更换时心律失常的发生率和 1 年死亡率的预测因素。

Incidence of Ventricular Arrhythmias and 1-Year Predictors of Mortality in Patients Treated With Implantable Cardioverter-Defibrillator Undergoing Generator Replacement.

机构信息

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Department of Molecular Medicine Unit of Cardiology Fondazione IRCCS Policlinico San MatteoUniversity of Pavia Italy.

Cardiocentro Ticino Lugano Switzerland.

出版信息

J Am Heart Assoc. 2021 Feb 16;10(4):e018090. doi: 10.1161/JAHA.120.018090. Epub 2021 Jan 30.

DOI:10.1161/JAHA.120.018090
PMID:33522246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7955330/
Abstract

Background When implantable cardioverter defibrillator (ICD) battery is depleted most patients undergo generator replacement (GR) even in the absence of persistent ICD indication. The aim of this study was to assess the incidence of ventricular arrhythmias and the overall prognosis of patients with and without persistent ICD indication undergoing GR. Predictors of 1-year mortality were also analyzed. Methods and Results Patients with structural heart disease implanted with primary prevention ICD undergoing GR were included. Patients were stratified based on the presence/absence of persistent ICD indication (left ventricular ejection fraction ≤35% at the time of GR and/or history of appropriate ICD therapies during the first generator's life). The study included 371 patients (82% male, 40% with ischemic heart disease). One third of patients (n=121) no longer met ICD indication at the time of GR. During a median follow-up of 34 months after GR patients without persistent ICD indication showed a significantly lower incidence of appropriate ICD shocks (1.9% versus 16.2%, <0.001) and ICD therapies. 1-year mortality was also significantly lower in patients without persistent ICD indication (1% versus 8.3%, =0.009). At multivariable analysis permanent atrial fibrillation, chronic advanced renal impairment, age >80, and persistent ICD indication were found to be significant predictors of 1-year mortality. Conclusions Patients without persistent ICD indication at the time of GR show a low incidence of appropriate ICD therapies after GR. Persistent ICD indication, atrial fibrillation, advanced chronic renal disease, and age >80 are significant predictors of 1-year mortality. Our findings enlighten the need of performing a comprehensive clinical reevaluation of ICD patients at the time of GR.

摘要

背景

当植入式心脏复律除颤器 (ICD) 的电池耗尽时,大多数患者即使没有持续的 ICD 指征,也会进行发电机更换 (GR)。本研究旨在评估有和无持续 ICD 指征的患者在进行 GR 后发生室性心律失常的发生率和整体预后。还分析了 1 年死亡率的预测因素。

方法和结果

研究纳入了患有结构性心脏病并植入一级预防 ICD 的患者,这些患者正在进行 GR。根据是否存在持续的 ICD 指征(在 GR 时左心室射血分数≤35%和/或在第一个发电机寿命期间有适当的 ICD 治疗史)对患者进行分层。研究包括 371 名患者(82%为男性,40%为缺血性心脏病)。三分之一的患者(n=121)在进行 GR 时已不再符合 ICD 指征。在 GR 后 34 个月的中位随访期间,无持续 ICD 指征的患者发生适当 ICD 电击(1.9%对 16.2%,<0.001)和 ICD 治疗的发生率明显较低。无持续 ICD 指征的患者 1 年死亡率也明显较低(1%对 8.3%,=0.009)。多变量分析发现,永久性心房颤动、慢性晚期肾功能不全、年龄>80 岁和持续的 ICD 指征是 1 年死亡率的显著预测因素。

结论

在进行 GR 时没有持续 ICD 指征的患者在进行 GR 后发生适当的 ICD 治疗的发生率较低。持续的 ICD 指征、心房颤动、慢性晚期肾功能疾病和年龄>80 岁是 1 年死亡率的显著预测因素。我们的研究结果表明,在进行 GR 时需要对 ICD 患者进行全面的临床重新评估。

相似文献

1
Incidence of Ventricular Arrhythmias and 1-Year Predictors of Mortality in Patients Treated With Implantable Cardioverter-Defibrillator Undergoing Generator Replacement.植入式心脏复律除颤器更换时心律失常的发生率和 1 年死亡率的预测因素。
J Am Heart Assoc. 2021 Feb 16;10(4):e018090. doi: 10.1161/JAHA.120.018090. Epub 2021 Jan 30.
2
Who still remains at risk of arrhythmic death at time of implantable cardioverter-defibrillator generator replacement?在植入式心脏复律除颤器发生器更换时,哪些人仍有发生心律失常性死亡的风险?
Pacing Clin Electrophysiol. 2017 Oct;40(10):1129-1138. doi: 10.1111/pace.13163. Epub 2017 Sep 15.
3
Incidence of appropriate anti-tachycardia therapies after elective generator replacement in patient with heart failure initially implanted with a defibrillator for primary prevention: Results of a meta-analysis.在因心力衰竭而首次植入心脏除颤器进行一级预防的患者中,选择性更换除颤器后抗心动过速治疗的发生率:荟萃分析结果。
Int J Cardiol. 2019 May 15;283:122-127. doi: 10.1016/j.ijcard.2018.12.068. Epub 2019 Jan 2.
4
Predictors and outcomes of cardiac resynchronization therapy extended to the second generator.预测因素和第二代心脏再同步治疗的结果。
Heart Rhythm. 2017 Dec;14(12):1793-1800. doi: 10.1016/j.hrthm.2017.09.002. Epub 2017 Sep 14.
5
The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.不再符合一级预防指征的患者在更换植入式心律转复除颤器发生器后植入式心律转复除颤器治疗的发生情况
J Cardiovasc Electrophysiol. 2016 Jun;27(6):724-9. doi: 10.1111/jce.12961. Epub 2016 Apr 20.
6
Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.心脏再同步治疗除颤器(CRT-D)患者更换器械时的适当植入式心律转复除颤器干预:是否需要从 CRT-D 降级为 CRT-起搏器?DECODE CRT-D 分析中的真实临床实践见解。
Europace. 2018 Sep 1;20(9):1475-1483. doi: 10.1093/europace/eux323.
7
Implantable cardioverter-defibrillator in the elderly: Predictors of appropriate interventions and mortality at 12-month follow-up.老年患者植入式心脏复律除颤器:12个月随访时恰当干预及死亡率的预测因素
Pacing Clin Electrophysiol. 2017 Dec;40(12):1368-1373. doi: 10.1111/pace.13215. Epub 2017 Nov 16.
8
Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.植入式心律转复除颤器更换后合适的植入式心律转复除颤器治疗的发生率和死亡率:来自真实世界全国性队列的结果。
Europace. 2019 Aug 1;21(8):1211-1219. doi: 10.1093/europace/euz121.
9
Persistence of ICD indication at the time of replacement in patients with initial implant for primary prevention indication: Effect on subsequent ICD therapies.初始植入用于一级预防指征的患者在更换时ICD指征的持续性:对后续ICD治疗的影响。
Indian Pacing Electrophysiol J. 2017 Mar-Apr;17(2):29-33. doi: 10.1016/j.ipej.2016.11.008. Epub 2016 Nov 14.
10
Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.二级预防性植入式心脏复律除颤器适应症患者中适当的植入式心脏复律除颤器治疗的发生率及预测因素
Europace. 2016 Feb;18(2):227-31. doi: 10.1093/europace/euv188. Epub 2015 Jun 10.

引用本文的文献

1
One-Year Mortality in Patients Undergoing an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Pulse Generator Replacement: Identifying Patients at Risk.接受植入式心脏复律除颤器或心脏再同步治疗脉冲发生器更换的患者的一年死亡率:识别高危患者。
J Clin Med. 2023 Aug 30;12(17):5654. doi: 10.3390/jcm12175654.
2
Incidence and Predictors of Implantable Cardioverter-defibrillator Therapies After Generator Replacement-A Pooled Analysis of 31,640 Patients' Data.发生器更换后植入式心律转复除颤器治疗的发生率及预测因素——对31640例患者数据的汇总分析
J Innov Card Rhythm Manag. 2022 Dec 15;13(12):5278-5293. doi: 10.19102/icrm.2022.13121. eCollection 2022 Dec.

本文引用的文献

1
Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.植入式心律转复除颤器更换后合适的植入式心律转复除颤器治疗的发生率和死亡率:来自真实世界全国性队列的结果。
Europace. 2019 Aug 1;21(8):1211-1219. doi: 10.1093/europace/euz121.
2
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment.最佳药物治疗下伴有中度左心室功能障碍患者的 ICD 替换。
Int J Cardiol. 2019 Oct 15;293:119-124. doi: 10.1016/j.ijcard.2019.06.072. Epub 2019 Jul 4.
3
Incidence of appropriate anti-tachycardia therapies after elective generator replacement in patient with heart failure initially implanted with a defibrillator for primary prevention: Results of a meta-analysis.
在因心力衰竭而首次植入心脏除颤器进行一级预防的患者中,选择性更换除颤器后抗心动过速治疗的发生率:荟萃分析结果。
Int J Cardiol. 2019 May 15;283:122-127. doi: 10.1016/j.ijcard.2018.12.068. Epub 2019 Jan 2.
4
Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator Replacement.植入型心律转复除颤器更换后治疗前和治疗中的恰当治疗风险与死亡风险。
Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006155. doi: 10.1161/CIRCEP.117.006155.
5
When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion?在电池耗尽时,何时不重新植入植入式心脏复律除颤器是安全的?
Card Electrophysiol Clin. 2018 Mar;10(1):137-144. doi: 10.1016/j.ccep.2017.11.014.
6
Declining Risk of Sudden Death in Heart Failure.心力衰竭患者猝死风险降低。
N Engl J Med. 2017 Jul 6;377(1):41-51. doi: 10.1056/NEJMoa1609758.
7
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会(HFA)特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
8
Implantable Cardioverter-Defibrillators at End of Battery Life: Opportunities for Risk (Re)-Stratification in ICD Recipients.植入式心脏复律除颤器在电池寿命末期:ICD 接受者风险(重新)分层的机会。
J Am Coll Cardiol. 2016 Feb 2;67(4):435-444. doi: 10.1016/j.jacc.2015.11.033.
9
Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life.首次电池寿命平稳后进行择期发生器更换后的除颤器电击发生率。
J Am Heart Assoc. 2014 Nov 10;3(6):e001289. doi: 10.1161/JAHA.114.001289.
10
Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.心脏再同步治疗中左心室射血分数的正常化与室性心律失常和临床结局的风险:来自多中心自动除颤器植入试验与心脏再同步治疗(MADIT-CRT)试验的结果。
Circulation. 2014 Dec 23;130(25):2278-86. doi: 10.1161/CIRCULATIONAHA.114.011283. Epub 2014 Oct 9.